Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Trehalose by Seelos Therapeutics for Oculopharyngeal Muscular Dystrophy: Likelihood of Approval
Trehalose is under clinical development by Seelos Therapeutics and currently in Phase III for Oculopharyngeal Muscular Dystrophy. According to GlobalData,...